Kevin Fitzgerald - Aug 12, 2024 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
CSO & EVP, Head of Research
Signature
By: Brett Budzinski, Attorney-in-Fact For: Kevin Fitzgerald
Stock symbol
ALNY
Transactions as of
Aug 12, 2024
Transactions value $
-$4,122,086
Form type
4
Date filed
8/14/2024, 04:12 PM
Previous filing
Jun 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Options Exercise $651K +6.67K +47.01% $97.72 20.8K Aug 12, 2024 Direct F1
transaction ALNY Common Stock Options Exercise $1.19M +14.1K +67.43% $85.00 34.9K Aug 12, 2024 Direct F1
transaction ALNY Common Stock Sale -$382K -1.42K -4.07% $268.66 33.5K Aug 12, 2024 Direct F1, F2
transaction ALNY Common Stock Sale -$2.61M -9.66K -28.85% $270.17 23.8K Aug 12, 2024 Direct F1, F3
transaction ALNY Common Stock Sale -$1.56M -5.74K -24.08% $271.32 18.1K Aug 12, 2024 Direct F1, F4
transaction ALNY Common Stock Sale -$1.07M -3.91K -21.63% $272.43 14.2K Aug 12, 2024 Direct F1, F5
transaction ALNY Common Stock Sale -$317K -1.16K -8.17% $273.73 13K Aug 12, 2024 Direct F1, F6
transaction ALNY Common Stock Sale -$37.1K -135 -1.04% $274.65 12.9K Aug 12, 2024 Direct F1
holding ALNY Common Stock 537 Aug 12, 2024 by Managed Account F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Stock Option (right to buy) Options Exercise $0 -14.1K -86.51% $0.00 2.19K Aug 12, 2024 Common Stock 14.1K $85.00 Direct F1, F8
transaction ALNY Stock Option (right to buy) Options Exercise $0 -6.67K -100% $0.00* 0 Aug 12, 2024 Common Stock 6.67K $97.72 Direct F1, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 All transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on May 10, 2024.
F2 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $268.53 to $269.52. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $269.90 to $270.87. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $271.02 to $271.99. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F5 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $272.23 to $272.99. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F6 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $273.32 to $274.01. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F7 Reflects shares of ALNY common stock acquired by the Reporting Person under the issuer 401(k) plan as a result of the issuer 401(k) matching contribution program.
F8 This stock option was fully vested and exercisable as of February 28, 2023.
F9 This stock option was fully vested and exercisable as of December 7, 2015.